6 research outputs found
Unexpected finding in an adult with ventricular fibrillation and an accessory pathway: Non-compaction cardiomyopathy
Early markers of atrial fibrillation recurrence after pulmonary vein isolation
Background: Postprocedural atrial extrasystole (AES) frequency predicts atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI) in patients with paroxysmal AF. However, the predictive value of preprocedural AES frequency is unknown. We investigate whether preprocedural AES frequency is a feasible marker to predict (timing of) AF recurrence after PVI. Methods: Patients (NÂ =Â 684) with paroxysmal or persistent AF undergoing first-time PVI were evaluated for (a) the frequency of AES/day on Holter recordings without AF prior to PVI, (b) AF episodes during the 90Â days blanking period, and (c) AF recurrences afterward. The correlation between AES/day and both development and timing of AF recurrences was tested. Results: Preprocedural AES/day was similar in patients with paroxysmal (66 [20-295] AES/day) and persistent AF (115 [12-248] AES/day, PÂ =.915). During the blanking period, 302 (44.2%) patients showed AF episodes. AF recurred in 379 (55.4%) patients at 203 (105-400) days after PVI. AF recurred more frequently in patients with persistent (NÂ =Â 104 [69.3%]) than in patients with paroxysmal AF (NÂ =Â 275 [51.5%], PÂ <.001). Frequency of AES prior to PVI was not correlated with development (PÂ =.203) or timing (PÂ =.478) of AF recurrences. AF recurrences occurred both more frequently (PÂ <.001) and earlier (PÂ <.000) in patients with AF during the blanking period. Conclusion: AES/day prior to PVI is not correlated with (timing of) AF during the blanking period or AF recurrences, and is therefore not a feasible marker for AF recurrences in patients with PAF. AF during the blanking period is correlated with AF recurrence
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II
BACKGROUND: The mechanisms behind the beneficial effects of
renin-angiotensin system blockade after myocardial infarction (MI) are not
fully elucidated but may include interference with tissue angiotensin II
(Ang II). METHODS AND RESULTS: Forty-nine pigs underwent coronary artery
ligation or sham operation and were studied up to 6 weeks. To determine
coronary angiotensin I (Ang I) to Ang II conversion and to distinguish
plasma-derived Ang II from locally synthesized Ang II, (125)I-labeled and
endogenous Ang I and II were measured in plasma and in infarcted and
noninfarcted left ventricle (LV) during (125)I-Ang I infusion. Ang II type
1 (AT(1)) receptor-mediated uptake of circulating (125)I-Ang II was
increased at 1 and 3 weeks in noninfarcted LV, and this uptake was the
main cause of the transient elevation in Ang II levels in the noninfarcted
LV at 1 week. Ang II levels and AT(1) receptor-mediated uptake of
circulating Ang II were reduced in the infarct area at all time points.
Coronary Ang I to Ang II conversion was unaffected by MI. Captopril and
the AT(1) receptor antagonist eprosartan attenuated postinfarct
remodeling, although both drugs increased cardiac Ang II production.
Captopril blocked coronary conversion by >80% and normalized Ang II uptake
in the noninfarcted LV. Eprosartan did not affect coronary conversion and
blocked cardiac Ang II uptake by >90%. CONCLUSIONS: Both circulating and
locally generated Ang II contribute to remodeling after MI. The rise in
tissue Ang II production during angiotensin-converting enzyme inhibition
and AT(1) receptor blockade suggests that the antihypertrophic effects of
these drugs result not only from diminished AT(1) receptor stimulation but
also from increased stimulation of growth-inhibitory Ang II type 2
receptors
Cohort profile of BIOMArCS: The BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands
__Purpose:__ Progression of stable coronary artery disease (CAD) towards acute coronary syndrome (ACS) is a dynamic and heterogeneous process with many intertwined constituents, in which a plaque destabilising sequence could lead to ACS within short time frames. Current CAD risk assessment models, however, are not designed to identify increased vulnerability for the occurrence of coronary events within a precise, short time frame at the individual patient level. The BIOMarker study to identify the Acute risk of a Coronary Syndrome (BIOMArCS) was designed to evaluate whether repeated measurements of multiple biomarkers can predict such 'vulnerable periods'.
__Participants:__ BIOMArCS is a multicentre, prospective, observational study of 844 patients presenting with ACS, either with or without ST-elevation and at least one additional cardiovascular risk factor.
__Methods and analysis:__ We hypothesised that patterns of circulating biomarkers that reflect the various pathophysiological components of CAD, such as distorted lipid metabolism, vascular inflammation, endothelial dysfunction, increased thrombogenicity and ischaemia, diverge in the days to weeks before a coronary event. Divergent biomarker patterns, identified by serial biomarker measurements during 1-year follow-up might then indicate 'vulnerable periods' during which patients with CAD are at high short-Term risk of developing an ACS. Venepuncture was performed every fortnight during the first half-year and monthly thereafter. As prespecified, patient enrolment was terminated after the primary end point of cardiovascular death or hospital admission for nonfatal ACS had occurred in 50 patients. A case-cohort design will explore differences in temporal patterns of circulating biomarkers prior to the repeat ACS
Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction
The renin-angiotensin system plays an important role in cardiovascular homeostasis by contributing to the regulation of blood volume, blood pressure, and vascular tone. Because AT1 receptors have been described in the coronary microcirculation, we investigated whether ANG II contributes to the regulation of coronary vascular tone and whether its contribution is altered during exercise. Since the renin-angiotensin system is activated after myocardial infarction, resulting in an increase in circulating ANG II, we also investigated whether the contribution of ANG II to the regulation of vasomotor tone is altered after infarction. Twenty-six chronically instrumented swine were studied at rest and while running on a treadmill at 1-4 km/h. In 13 swine, myocardial infarction was induced by ligation of the left circumflex coronary artery. Blockade of AT1 receptors (irbesartan,